"Be Well MD is an outpatient medical practice providing personalized healthcare to aging adults. Our clinicians provide services in Austin, Texas and Eastern Nebraska. Be Well MD services are conveniently accessible to you, providing care through our in-home concierge service and in medical clinics located in senior living communities. No matter the level of care you choose, the personalized attention you receive may help avoid unnecessary trips to the emergency room or urgent care and prevent exposure to infections in busy waiting rooms. Your desired level of care determines insurance coverage."

During the past decade, Advanced Clinical Research-Be Well MD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Clinical Research-Be Well MD" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Clinical Research-Be Well MD" are "CDI" (1 trials), "Clostridium Difficile" (1 trials), "Clostridium Difficile Infection" (1 trials), "Clostridium Difficile Infection Recurrence" (1 trials) and "Postmenopausal Osteoporosis" (1 trials). Many other conditions were trialed in "Advanced Clinical Research-Be Well MD" in a lesser frequency.

Most popular intervention types in "Advanced Clinical Research-Be Well MD" are "Biological" (1 trials), "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "VE303" (1 trials), "abaloparatide" (1 trials), "abaloparatide solid microstructured transdermal system" (1 trials) and "mRNA-1273" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Clinical Research-Be Well MD" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Advanced Clinical Research-Be Well MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Advanced Clinical Research-Be Well MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Clinical Research-Be Well MD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".